CHPA Statement on FDA Commissioner Gottlieb’s Resignation

WASHINGTON, D.C. (March 5, 2019) The Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville issued the following statement in response to the announcement regarding Food and Drug Administration (FDA) Commissioner Scott Gottlieb’s resignation. 

“Commissioner Gottlieb has been a vocal advocate for ensuring consumer access to safe and reliable self-care options including over-the-counter (OTC) medicines and dietary supplements. His tenure at FDA has been marked by tremendous progress on modernizing the regulatory framework for OTC medicines and beginning similar work for dietary supplements. CHPA will continue to advocate for these important public health initiatives moving forward. 

“Gottlieb effectively brought his previous experience as a physician, former FDA staffer, clinical researcher, and cancer survivor to the Agency, creating strong, innovative plans to advance public health. CHPA thanks Commissioner Gottlieb for his active leadership of the Agency.”  

The Consumer Healthcare Products Association (CHPA) is the 138-year-old national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to empowering self-care by preserving and expanding choice and availability of consumer healthcare products.


Contact: Lauren Bloomberg (